Literature DB >> 16820640

Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization.

Eugene A Grossi1, Gregory A Crooke, Paul L DiGiorgi, Charles F Schwartz, Ulrich Jorde, Robert M Applebaum, Greg H Ribakove, Aubrey C Galloway, Juan B Grau, Stephen B Colvin.   

Abstract

BACKGROUND: Mild and moderate functional ischemic mitral insufficiency present at the time of surgical revascularization present clinical uncertainty. It is unclear whether the relatively poor outcomes in this cohort are dependent on valvular function or related to left ventricular dysfunction. The purpose of this study was to examine the early and late outcomes in patients with less-than-severe functional ischemic mitral insufficiency at the time of isolated coronary artery bypass grafting (CABG). METHODS AND
RESULTS: From 1996 through 2004, 2242 consecutive patients undergoing isolated CABG were identified as having none to moderate mitral regurgitation (MR) and no valve leaflet pathology. All of the patients at this single institution routinely had an intraoperative transesophageal echocardiography, prospectively quantified MR, and ejection fraction (EF). The New York State Cardiac Surgery Reporting System infrastructure was used to prospectively collect in-hospital patient variables and outcomes. Social Security Death Benefit Index was used to determine long-term survival. Odds ratio and significance (P value) are presented for each determined risk factor. There were 841 patients (37.5%) with no MR, 1137 (50.7%) with mild MR, and 264 (11.8%) with moderate MR. The patients with moderate MR were more likely to be older, female, and have more renal disease, previous MI, congestive heart failure, previous cardiac surgery, and lower EFs. Hospital mortality was independently and significantly associated with renal disease, decreasing EF, increasing age, previous cardiac operation, and cerebral vascular disease. Multivariable analysis revealed decreased survival with increasing age, previous operation, congestive heart failure, diabetes, nonelective operation, decreasing EF, and the presence of moderate MR (expbeta = 1.49; P=0.007) and mild MR (expbeta = 1.34; P=0.033).
CONCLUSIONS: Independent of ventricular function, mild and moderate functional mitral insufficiency are associated with significantly decreased survival in patients undergoing CABG. Whether correction of moderate functional MR at the time of CABG improves outcome still needs to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 16820640     DOI: 10.1161/CIRCULATIONAHA.105.001230

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Long-term influence of mild or moderate ischemic mitral regurgitation after off-pump coronary artery bypass surgery.

Authors:  Jong-Myeon Hong; Raymond Cartier; Michel Pellerin; Philippe Demers; Denis Bouchard; P Couture
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

2.  Computational modeling of pathophysiologic responses to exercise in Fontan patients.

Authors:  Ethan Kung; James C Perry; Christopher Davis; Francesco Migliavacca; Giancarlo Pennati; Alessandro Giardini; Tain-Yen Hsia; Alison Marsden
Journal:  Ann Biomed Eng       Date:  2014-09-27       Impact factor: 3.934

Review 3.  Surgical Strategies for Management of Mitral Regurgitation: Recent Evidence from Randomized Controlled Trials.

Authors:  George Tolis; Thoralf M Sundt
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

Review 4.  Ischemic mitral regurgitation: not only a bystander.

Authors:  Philippe Unger; Julien Magne; Chantal Dedobbeleer; Patrizio Lancellotti
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

5.  "RFEF" and mitral regurgitation jet direction: surrogate markers for likelihood of left ventricle reverse remodeling in patients with moderate chronic ischemic mitral regurgitation.

Authors:  Sumbul Siddiqui; Amber Malhotra; Komal Shah; Pankaj Garg; Pranav Sharma; Vivek Wadhawa; Kartik Patel; Anand Shukla
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-10-18

6.  Moderate ischemic mitral regurgitation: Is there a case for early intervention?

Authors:  Hani K Najm; Ahmed A Arifi; Ahmed S Omran; Munir Ahmad
Journal:  J Saudi Heart Assoc       Date:  2010-05-11

Review 7.  Percutaneous and off-pump treatments for functional mitral regurgitation.

Authors:  Kiyotaka Fukamachi
Journal:  J Artif Organs       Date:  2008-04-15       Impact factor: 1.731

8.  Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes.

Authors:  Batric Popovic; Nelly Agrinier; Damien Voilliot; Mazen Elfarra; Jean Pierre Villemot; Pablo Maureira
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

9.  Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation.

Authors:  Jimmy MacHaalany; Olivier F Bertrand; Kim O'Connor; Eltigani Abdelaal; Pierre Voisine; Éric Larose; Éric Charbonneau; Olivier Costerousse; Jean-Pierre Déry; Mario Sénéchal
Journal:  Cardiovasc Ultrasound       Date:  2014-04-03       Impact factor: 2.062

10.  Cardio-autonomic functions and sleep indices before and after coronary artery bypass surgery.

Authors:  Khamis Mohammed Al-Hashmi; Mohammed A Al-Abri; Deepali S Jaju; Mirdavron Mukaddirov; Abdulnasir Hossen; Mohammed O Hassan; Mostafa Mesbah; Hilal Ali Al-Sabti
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.